ArticleBioengineering (Basel, Switzerland)2024
MRI-Driven Alzheimer's Disease Diagnosis Using Deep Network Fusion and Optimal Selection of Feature.
Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A lightweight CVTC model for accurate Alzheimer's MRI analysis and lesion annotation.NPJ digital medicine · 2026Article
- Advances in AI-based diagnosis of Alzheimer's disease using MRI: a comprehensive survey.Frontiers in medicine · 2026Review
- Convolutional neural networks in brain disease diagnosis: a unified review of Alzheimer's, Parkinson's, and brain tumor classification.Frontiers in neuroscience · 2026Review
- Deep Learning-Based Diagnosis Algorithm for Alzheimer's Disease.Journal of imaging · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease (AD) is a degenerative neurological condition characterized by cognitive decline, memory loss, and reduced everyday function, which eventually causes dementia. Symptoms develop years after the disease begins, making early detection difficult. While AD remains incurable, timely detection and prompt treatment can substantially slow its progression. This study presented a framework for automated AD detection using brain MRIs. Firstly, the deep network information (i.e., features) were extracted using various deep-learning networks. The information extracted from the best deep networks (EfficientNet-b0 and MobileNet-v2) were merged using the canonical correlation approach (CCA). The CCA-based fused features resulted in an enhanced classification performance of 94.7% with a large feature vector size (i.e., 2532). To remove the redundant features from the CCA-based fused feature vector, the binary-enhanced WOA was utilized for optimal feature selection, which yielded an average accuracy of 98.12 ± 0.52 (mean ± standard deviation) with only 953 features. The results were compared with other optimal feature selection techniques, showing that the binary-enhanced WOA results are statistically significant (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.